Talphera, Inc. balance sheet
At the end of fiscal 2025, Talphera, Inc. had total assets of $29.7m, total liabilities of $12.7m and shareholders' equity of $17.0m. It held $5.9m in cash against $0 of debt: net cash of $5.9m.
Balance sheet
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8 | 48 | 88 | 60 | 108 | 80 | 53 | 88 | 15 | 22 | 8 | 15 | 6 | 9 | 6 | 1 |
| Receivables | — | — | — | 0 | 3 | 6 | 2 | 0 | 0 | 1 | 0 | 0 | — | — | — | — |
| Inventory | — | — | — | — | 0 | 2 | 1 | 1 | 3 | 2 | 1 | 1 | — | — | — | — |
| Total current assets | 38 | 62 | 105 | 76 | 119 | 89 | 63 | 108 | 72 | 47 | 50 | 25 | 12 | 9 | 21 | 18 |
| Total assets | 41 | 65 | 110 | 86 | 128 | 100 | 76 | 121 | 91 | 66 | 78 | 47 | 20 | 18 | 30 | 27 |
| Accounts payable | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 0 |
| Deferred revenue (current) | — | — | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — |
| Total current liabilities | 8 | 14 | 7 | 14 | 13 | 10 | 14 | 16 | 14 | 18 | 19 | 14 | 5 | 3 | 4 | 4 |
| Short-term debt | 4 | 7 | — | 7 | 5 | 3 | 8 | 9 | 5 | 9 | 9 | 5 | 0 | — | — | — |
| Long-term debt | 15 | 9 | 14 | 18 | 16 | 19 | 11 | 3 | 21 | 13 | 5 | 0 | — | — | — | — |
| Total debt | 19 | 16 | 14 | 25 | 21 | 22 | 19 | 12 | 25 | 22 | 14 | 6 | 0 | 0 | 0 | 0 |
| Total liabilities | 23 | 31 | 37 | 40 | 95 | 105 | 112 | 116 | 133 | 122 | 114 | 26 | 6 | 10 | 13 | 12 |
| Shareholders' equity | 17 | 34 | 73 | 47 | 33 | −5 | −37 | 4 | −41 | −56 | −36 | 22 | 14 | 8 | 17 | 14 |
| Net debt (negative = net cash) | 11 | −32 | −74 | −35 | −87 | −59 | −34 | −76 | 10 | −0 | 6 | −10 | −6 | −9 | −6 | −1 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | — | — | — | 17m | — | 49m | 52m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 12 | 9 | 6 | 8 | 22 | 21 | 21 | 18 |
| Total assets | 21 | 18 | 15 | 17 | 31 | 30 | 30 | 27 |
| Accounts payable | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Total current liabilities | 3 | 3 | 2 | 3 | 3 | 4 | 4 | 4 |
| Total liabilities | 11 | 10 | 9 | 10 | 12 | 13 | 12 | 12 |
| Shareholders' equity | 10 | 8 | 6 | 7 | 19 | 17 | 18 | 14 |
| Shares outstanding | 17m | 17m | 17m | 21m | 46m | 49m | 50m | 52m |
Compare with peers
- PRF Technologies Ltd. balance sheet
- Akanda Corp. balance sheet
- Scienture Holdings, Inc. balance sheet
- 60 Degrees Pharmaceuticals, Inc. balance sheet
- China SXT Pharmaceuticals, Inc. balance sheet
Head to head: PRFX vs TLPHAKAN vs TLPHSCNX vs TLPH
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies